Stay updated with breaking news from Agvhd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Perhaps surprisingly when considering interest rates are rising – usually a negative for high-yield assets – high-dividend stocks and the related exchange traded funds are delivering for investors this year.
Low-volatility stocks are outperforming the broader market this year. Same goes for high-dividend equities.
Broadly speaking, dividend stocks and the related exchange traded funds are among the most durable shelter-from-the-storm plays.
FRIDAY, Aug. 26, 2022 (HealthDay News) -- The U.S. Food and Drug Administration has approved Imbruvica (ibrutinib) for pediatric patients with chronic graft versus host disease (cGVHD) after failure of
Franklin Templeton president and CEO Jenny Johnson spoke with NYSE's Judy Shaw for "ETF Leaders, Powered by the New York Stock Exchange."